Collection 圖書 [1/1] 會議論文/會議摘要 [16/27] 期刊論文 [65/66] Siblings 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:30(31.91%) 含全文筆數:82(87.23%) 文件下載次數統計 下載大於0次:82(100.00%) 下載大於100次:80(97.56%) 檔案下載總次數:26086(0.49%) 最後更新時間: 2024-11-28 13:42 Top Upload Loading... Top Download Loading... Recent Submissions Registry of genetic alterations of ... Systemic treatments in pancreatic c... An integrated microfluidic device f... Phase 1 studies of D07001-F4 and D0... The experience of neoadjuvant chemo... Real-world data validation of NAPOL... Elevated PD-L1 expression and micro... Adjuvant therapy in biliary tract c... The association between UGT1A1 poly... Revisiting the cerebral hemodynamic...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 76-94 of 94. (4 Page(s) Totally) << < 1 2 3 4  View [10|25|50] records per page

Date	Title	Relation
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
2015-10	Epigenetic regulation in the carcinogenesis of cholangiocarcinoma	International Journal of Biochemistry and Cell Biology. 2015 Oct;67:110-114.
2015-08	Primary gastrointestinal stromal tumor of the liver in an anorectal melanoma survivor: A case report	Oncology Letters. 2015 Aug;10(4):2366-2370.
2015-05	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	Annals of Oncology. 2015 May;26(5):943-949.
2015-04	The potent activation of Ca2+-activated K+ current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition	Journal of Pharmacological Sciences. 2015 Apr;127(4):404-413.
2015-03	Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients	Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586.
2014-11-30	MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors	Oncotarget. 2014 Nov 30;5(22):11723-11736.
2014-10	Stimulation of electroporation-induced inward currents in glioblastoma cell lines by the heat shock protein inhibitor AUY922	Clinical and Experimental Pharmacology and Physiology. 2014 Oct;41(10):830-837.
2014-07-31	Evaluation of decellularized extracellular matrix of skeletal muscle for tissue engineering	International Journal of Artificial Organs. 2014 Jul 31;37(7):546-555.
2014-02	The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: A nation-wide cancer registry-based study	BMC Cancer. 2014 Feb 18;14:Article number 102.
2014-01	Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial	Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267.
2013-06-20	Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations	PLoS ONE. 2013 Jun 20;8(6):Article number e65762.
2013-05	Impact of virologic factors on recurrence-free survival in HBV-related hepatocellular carcinoma after surgical resection: Post hoc analysis from a prospective study with long-term follow-up	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e15032.
2013-03-12	A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway	PLoS ONE. 2013 Mar 12;8(3):Article number e58953.
2013-02	Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors	Autophagy. 2013 Feb;9(2):220-233.
2012-09	Heat shock protein 90 inhibition downregulates c-Kit expression in gist cells through diminishing transcription and enhancing protein degradation via both autophagy and proteasome pathways	Annals of Oncology. 2012 Sep;23(Suppl. 9):538.
2012-03	Involvement of autophagy in endogenous and NVP-AUY922-induced C-kit degradation in both imatinib-sensitive and -resistant gastrointestinal stromal tumor cells	Annals of Oncology. 2012 Mar;23(Suppl. 1):28.
2011-05	Novel Hsp90 inhibitor NVP-AUY922 downregulates mutant c-Kit protein through transcription and enhancing protein degradation via both proteasome and autophagy-mediated pathways	Drug Metabolism Reviews. 2011 May;43(Suppl. 1):78-79.
2011-02	Effect of inhibition of heat-shock protein 90 on mutant c-Kit protein as modulated by mRNA expression and protein degradation through both proteasome and autophagy-mediated pathways	Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4):Abstract Number 54

Showing items 76-94 of 94. (4 Page(s) Totally) << < 1 2 3 4  View [10|25|50] records per page